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Abstract
Conventional in vivo assays to determine the relative pathogenicity of yeast isolates rely upon the use of a range of mammalian species.
The purpose of the work presented here was to investigate the possibility of using an insect (Galleria mellonella) as a model system for in
vivo pathogenicity testing. The haemolymph of G. mellonella larvae was inoculated with PBS containing different concentrations of
stationary phase yeasts of the genus Candida by injection at the last pro-leg. Larvae were incubated at 30‡C and monitored over 72 hours.
Results indicate that G. mellonella can be killed by the pathogenic yeast Candida albicans and by a range of other Candida species but not to
a significant extent by the yeast Saccharomyces cerevisiae. The kill kinetics for larvae inoculated with clinical and laboratory isolates of
C. albicans indicate the former class of isolates to be more pathogenic. Differences in the relative pathogenicity of a range of Candida species
may be distinguished using G. mellonella as a model. This work indicates that G. mellonella may be employed to give results consistent with
data previously obtained using mammals in conventional in vivo pathogenicity testing. Larvae of G. mellonella are inexpensive to culture,
easy to manipulate and their use may reduce the need to employ mammals for routine in vivo pathogenicity testing with a concomitant
reduction in mammalian suffering. ß 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
A variety of mammalian species have been employed to
elucidate the role of the immune system in combating
fungal infections [1^6] and have contributed to our under-
standing of the interactions between pathogenic fungi and
host tissue in cases of human disease [7,8]. In addition,
animal models have proved invaluable in establishing the
pathogenicity of various fungi through in vivo tests [9,10].
The aim of the work presented here was to determine
whether an insect could be used to distinguish di¡erences
in the relative pathogenicities of various Candida species.
Such a model would have a number of advantages when
compared to the use of mammals for in vivo testing in-
cluding ease of culture and the absence of mammalian
su¡ering often associated with tests of this nature. Larvae
of Galleria mellonella (Lepidoptera: Galleriidae, the wax
moth) have previously been used to examine properties
associated with the pathogenicity of wild-type and lipo-
polysaccharide de¢cient mutants of Pseudomonas aerugi-
nosa [11] and in studies incorporating Proteus mirabilis
[12], Escherichia coli and Bacillus cereus [13]. Insects
such as Drosophila melanogaster and Spodoptora littoralis
have also been used to quantify the toxicity of secondary
metabolites from a number of di¡erent Penicillium isolates
[14]. The cockroach (Blattella germanica) has been em-
ployed in studies on the pathogenicity of Aspergillus £avus
[15].
The immune response of insects such as G. mellonella is
similar to that of mammals in that it consists of structural
and passive barriers as well as cellular and humoral re-
sponses which are performed by haemocytes within the
haemolymph [16]. Six types of haemocytes have been iden-
ti¢ed in insects and some (plasmatocytes and granulocytes)
are involved in phagocytosis, encapsulation and nodule
formation [17] which are important elements of the insect’s
cellular defences against bacteria and unicellular fungi
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[13]. Larger parasites are encapsulated and nodule forma-
tion occurs in response to a large number of invading
microorganisms [18]. Other humoral factors involved in
insect immunity to infection include lysozyme, lectins
and the prophenoloxidase cascade [16]. The insect immune
response to microorganisms has been shown to involve a
change in the circulating haemocyte population and syn-
thesis of new haemolymph proteins [12]. Active haemo-
static factors which repair wounds in the cuticle and limit
the development of further infection have also been iden-
ti¢ed [18].
While mammalian models have been used extensively to
elucidate the immune response to fungi and the factors
a¡ecting the interaction of fungal pathogens with host
tissue, they are expensive to use and undoubtedly involve
some element of animal su¡ering. The possibility of using
an insect model o¡ers many advantages when compared
to conventional mammalian systems for in vivo pathoge-
nicity testing of yeasts. Larvae of G. mellonella are easy to
culture and inoculate, a large number of insects may be
inoculated in a relatively short period of time and results
may be obtained within 48^72 h. In addition, insect larvae
are inexpensive to purchase and o¡er the possibility of
obtaining data on the relative virulence of pathogenic fun-
gi without the need to use mammals.
2. Materials and methods
2.1. Insect larvae
Sixth instar larvae of G. mellonella were obtained from
the Meal Worm Company, She⁄eld, England. Larvae
were stored in wood shavings in the dark at 15‡C prior
to use. All larvae were used within 3 weeks of receipt.
2.2. Yeast strains and culture conditions
Laboratory isolates of Candida albicans used in this
study included MEN (Serotype B, originally isolated
from an eye infection and a kind gift from Dr. D. Ker-
ridge, Cambridge, UK), ATCC 10231 and ATCC 44990
(ader, thr3) (obtained from the American Type Culture
Collection, Maryland, USA). C. albicans 24104, 24135
and 24069 were isolated from symptomatic vaginitis pa-
tients [19]. Candida tropicalis NCPF 3109, Candida pseu-
dotropicalis NCPF 3234, Candida krusei NCPF 3100, Can-
dida parapsilosis NCPF 3209, Candida glabrata NCPF
4733 (obtained from the National Collection of Pathogen-
ic Fungi, Bristol, UK) and Saccharomyces cerevisiae JJ1A
(arg3, thr3) were also employed during the course of this
work.
Yeasts were grown in YEPD broth (2% (w/v) glucose
(Sigma Chemical Co., Dublin, Ireland), 2% (w/v) bacto-
peptone (Difco Laboratories, Detroit, USA), 1% (w/v)
yeast extract (Oxoid Ltd., Basingstoke, UK) at 30‡C and
200 rpm in an orbital incubator. Stocks were maintained
on YEPD agar (as above but solidi¢ed by the addition of
2% (w/v) agar (Difco)) at 4‡C and subcultured every 6^8
weeks.
2.3. Inoculation of insects with Candida species
Candida species were grown to the stationary phase in
YEPD broth at 30‡C and 200 rpm in an orbital incubator.
Yeast cells were harvested by centrifugation in a Beck-
mann GS-6 centrifuge (5 min, 2300Ug), washed three
times and resuspended in sterile phosphate bu¡ered saline
(PBS, 0.01 M, pH 7.4). G. mellonella larvae, in groups of
ten, were inoculated by injection into the haemocoel with
20 Wl sterile PBS containing di¡erent concentrations of
yeasts through the last pro-leg as described previously
[11^13]. The syringe used for inoculation was an SGE
1 ml gas tight syringe (SGE Scienti¢c Pty. Ltd., Mel-
bourne, Australia) with a needle diameter of 0.75 mm.
Three controls were employed in all assays: the ¢rst
(control) consisted of larvae which were untouched and
maintained at the same temperature as the test larvae,
the second (injected control) contained larvae whose pro-
leg was pierced with the end of the inoculation needle but
which were not inoculated with yeast or PBS while the
third (PBS control) were inoculated with 20 Wl sterile
PBS through the last pro-leg. Larvae were placed in sterile
petri dishes and incubated in the dark at 30‡C in a sta-
tionary incubator. Mortality rates were determined over a
72 h period. Larval death was assessed by the lack of
movement of larvae in response to stimulation together
with discolouration of the cuticle. Stationary phase yeast
cells to be heat killed were harvested by centrifugation,
washed, resuspended in PBS and subsequently boiled for
20 min. Heat killed cells were washed three times and
resuspended in sterile PBS prior to dilution to the appro-
priate density and inoculation into the test larvae.
Ten larvae were employed per treatment and assays
were performed on three independent occasions. Results
represent the mean percentage survival of larvae following
the combination of the data from all experiments.
2.4. Recovery of C. albicans from G. mellonella larvae
Cells of C. albicans MEN were recovered from cadavers
of G. mellonella larvae that had been incubated for 48 h
following inoculation with yeast. Haemolymph samples
were collected onto glass slides and immediately heat ¢xed
by passing through a £ame 3^4 times. Samples were
stained with 1% (w/v) crystal violet solution for 20 min.
This was washed from the slides with excess distilled water
and samples were stained with Lugol’s iodine for 1 min.
The Lugol’s iodine was washed o¡ with excess water and
2^3 drops of acetone were placed on the samples for 5 s.
The presence of C. albicans in the sample was determined
microscopically.
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3. Results
3.1. Pathogenicity of C. albicans and S. cerevisiae in
G. mellonella larvae
In vivo pathogenicity tests should be able to distinguish
between pathogenic and non-pathogenic isolates and to
detect di¡erences in the relative pathogenicities of related
microbes. In order to establish whether G. mellonella lar-
vae would be capable of demonstrating di¡erences in the
pathogenicity of virulent and non-virulent yeasts initial
experiments sought to examine the response of larvae to
inoculation with C. albicans and S. cerevisiae. The patho-
genicity of C. albicans is well established [1^3,7] and
although the pathogenicity of some isolates of S. cerevisiae
has been recognised in recent years it is generally regarded
that this yeast is, at best, a weak pathogen with low levels
of virulence [9,20].
Larvae were inoculated through the last pro-leg with
20 Wl of PBS containing 2U102, 2U103, 2U104, 2U105
or 2U106 stationary phase cells of either species. Larvae
were incubated at 30‡C and the mortality rates were de-
termined over a 72 h period. The results (Fig. 1) indicate
that mortality rates were higher when larvae were inocu-
lated with C. albicans MEN than with S. cerevisiae JJ1A
at cell concentrations of 2U105 and 2U106 per 20 Wl in-
oculum. The greatest mortality rates were observed in
treatments incorporating C. albicans MEN with total lar-
val kill being recorded at an inoculum of 2U106 following
48 h incubation. In contrast, the mortality rate for larvae
inoculated with S. cerevisiae at the same cell concentration
was 30% at 48 h incubation. Experiments incorporating
isolates of S. cerevisiae associated with disease in humans
also revealed insigni¢cant levels of larval death (data not
presented). At the lower inoculum densities (2U102 to
2U104 yeasts per 20 Wl aliquot) mortality rates for the
two yeast species were comparable. Low levels of larval
death occurred in the three sets of controls which may
have resulted from the unavoidable handling of the larvae
in the initial stages of the assays.
The appearance of untreated G. mellonella larvae and
those inoculated with C. albicans MEN following incuba-
tion for 48 h is presented in Fig. 2. The dark colour of
larvae that have been infected with yeast is associated with
encapsulation and the subsequent production of the pig-
ment melanin, an immune response by the insect to non-
self matter such as fungi and bacteria [21].
Fig. 1. Percentage survival of G. mellonella larvae following inoculation with C. albicans or S. cerevisae. Larvae were inoculated at the last pro-leg and
incubated at 30‡C for 72 h. All values represent the mean þ standard deviation of data from three independent experiments.
Fig. 2. G. mellonella larvae before (a) and after inoculation with 2U106
C. albicans for 48 h (b). The discolouration of the cadavers in b is due
to melanisation. (Scale : U0.8.)
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3.2. Virulence of live and heat killed C. albicans MEN in
G. mellonella
Larvae of G. mellonella may be used to distinguish be-
tween a pathogenic yeast (C. albicans) and a non-patho-
genic yeast (S. cerevisiae) in in vivo tests. One possibility
for the death of larvae inoculated with C. albicans was the
development of an allergic reaction to the presence of a
large number of yeast cells in the insect’s haemolymph
[16]. To examine this possibility, larvae were inoculated
with a range of concentrations of heat killed and viable
C. albicans MEN in 20 Wl volumes.
The results indicate (Fig. 3) that mortality rates were
greater at the higher cell concentrations when larvae
were inoculated with viable yeast cells. Mortality rates
observed for larvae inoculated with viable C. albicans
MEN at concentrations of 2U106, 2U105, 2U104 and
following 72 h incubation were 90%, 20% and 30% respec-
tively. Corresponding values obtained using heat killed C.
albicans MEN were 20%, 5% and 10% respectively. These
data strongly suggest that the ability of C. albicans to kill
larvae of G. mellonella requires the presence of viable yeast
cells and that death is not due to the onset of an allergic
reaction to the presence of a large number of yeast cells in
the haemolymph.
Melanisation is an important element of the insect’s
immune response to the presence of C. albicans (see Fig.
2b), however the fate of C. albicans in the insect’s haemo-
lymph remains to be established. C. albicans is a dimor-
phic yeast being capable of interconverting between a bud-
ding and a hyphal or ¢lamentous mode of growth and
both forms are evident in human tissue infected with C.
albicans [2,7,22]. Cells of C. albicans MEN were recovered
from G. mellonella in order to determine whether cells
remained in the budding phase or whether hyphal forms
were the predominant growth form.
Following incubation of larvae that had been inoculated
with 2U106 C. albicans MEN for 48 h, haemolymph was
obtained from dead larvae by piercing the cuticle with a
sterile needle. Samples were placed on glass slides, heat
¢xed and stained as described (Section 2.4). Examination
of slides (Fig. 4) revealed that C. albicans was present in
the haemolymph of G. mellonella indicating that not all
yeasts were encapsulated by the insect’s immune response.
The majority of yeast were budding with very few hyphal
forms evident indicating that C. albicans in the haemo-
lymph retains the budding mode of growth and does not
form hyphae to a signi¢cant extent.
3.3. Virulence of clinical and laboratory isolates of
C. albicans in larvae of G. mellonella
Clinical isolates of C. albicans exhibit more pronounced
virulence levels than isolates that have been cultured for
long periods in the laboratory [22]. Larvae of G. mellonella
were inoculated with cells of clinical and laboratory iso-
Fig. 3. Percentage survival of G. mellonella larvae following inoculation with live or heat killed C. albicans MEN. Larvae were inoculated with between
2U102 and 2U106 viable or heat killed cells and incubated at 30‡C for 72 h. Values represent the mean þ standard deviation of data from three inde-
pendent experiments.
Fig. 4. Photomicrograph of cells of C. albicans present in insect haemo-
lymph 48 h after inoculation. Haemolymph was extracted from insect
cadavers heat ¢xed, and stained with crystal violet and Lugol’s iodine.
Budding cells (b) and a hyphal form (h) are visible. (Magni¢cation
U1000.)
FEMSIM 1165 7-1-00
G. Cotter et al. / FEMS Immunology and Medical Microbiology 27 (2000) 163^169166
lates of C. albicans to determine whether di¡erences in
pathogenicity could be distinguished using this model. A
number of clinical isolates, obtained from patients with
symptoms of vulvovaginal candidosis [19], and laboratory
isolates, which had been cultured in the laboratory for at
least 3 years, were selected for this work.
Clinical and laboratory isolates of C. albicans were
grown to the stationary phase in YEPD broth overnight
at 30‡C and 200 rpm in an orbital incubator. Cells were
harvested by centrifugation, washed with PBS and intro-
duced into G. mellonella larvae at the last pro-leg at a
density of 2U106 per 20 Wl aliquot. The results (Fig. 5)
reveal that greater and faster larval mortality rates were
observed when the three clinical isolates of C. albicans
were employed. Following 72 h incubation, mortality rates
for larvae inoculated with the clinical isolates 24135, 24069
and 24105 were 100%, 85% and 85% respectively. Mortal-
ity rates for larvae inoculated with the laboratory isolates
ATCC 10231, ATCC 44990 and MEN after 72 h incuba-
tion were 20%, 40% and 50% respectively.
3.4. Comparison of pathogenicity of a number of Candida
species in larvae of G. mellonella
C. albicans is the most pathogenic yeast of the genus
Candida [22]. The non-albicans Candida species vary in
their pathogenicity and a hierarchy has been shown to
exist in terms of the ability to cause disease in mammals
[23^25]. Experiments were performed incorporating vari-
ous Candida species to determine if di¡erences in the path-
ogenicity of non-albicans Candida species could be de-
tected using G. mellonella larvae.
A range of Candida species frequently associated with
disease in humans were selected and these varied from the
highly pathogenic (e.g. C. albicans) [7,22,24] to those of
low or negligible pathogenicity (e.g. C. krusei) [25]. Sta-
Fig. 5. Percentage survival of G. mellonella larvae following inoculation with laboratory or clinical isolates of C. albicans. Larvae were inoculated with
2U106 cells and incubated at 30‡C for 72 h. Values represent the mean þ standard deviation of data from three independent experiments.
Fig. 6. Percentage survival of G. mellonella larvae following inoculation with a range of Candida species. Larvae were inoculated with 2U106 cells and
incubated at 30‡C for 72 h. Values represent the mean þ standard deviation of data from three independent experiments.
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tionary phase yeast cells were prepared as described and
larvae were inoculated with 2U106 cells of each species at
the last pro-leg. The results (Fig. 6) indicate the existence
of a hierarchy among the Candida species with C. albicans
proving the most pathogenic of the species tested. Follow-
ing an incubation period of 72 h mortality rates for larvae
inoculated with C. albicans were 90% while those for the
other species were: C. tropicalis : 70% mortality, C. para-
psilosis : 45%, C. pseudotropicalis : 45%, C. krusei : 20% and
C. glabrata : 0%. A similar trend is also evident after 48 h
incubation with those larvae inoculated with C. albicans
again showing the highest mortality rates.
4. Discussion
A number of mammalian models have been used to
determine the relative pathogenicity of medically impor-
tant fungi [1,2,5,26]. The data presented here indicate
that G. mellonella larvae can be employed to di¡erentiate
between pathogenic and non-pathogenic yeast species and
to demonstrate di¡erences in the pathogenicity of yeasts of
the genus Candida. C. albicans MEN kills larvae to a
greater extent than the non-pathogenic S. cerevisiae JJ1A
and the di¡erences in relative pathogenicity may be ex-
plained by the more extensive array of virulence factors
exhibited by C. albicans [22,27]. Heat killed cells of
C. albicans MEN were shown to be less pathogenic than
viable yeast which indicates that the expression of factors
associated with viable yeast may be necessary to kill lar-
vae. These data also indicate that larval death is not due
to the development of an allergic response as a result of
the presence of large numbers of yeast cells in the insect’s
haemolymph [16].
Assays incorporating both clinical and laboratory iso-
lates of C. albicans indicated that the clinical isolates had a
greater ability to kill G. mellonella. These observations
indicate that the greater mortality rates observed for G.
mellonella larvae when inoculated with clinical isolates of
C. albicans may be due to the elevated expression of vir-
ulence factors [7,22]. Results obtained using G. mellonella
as an in vivo model indicate the existence of a hierarchy
among Candida species with respect to their ability to kill
larvae of G. mellonella, i.e. C. albicanssC. tropicalissC.
parapsilosissC. pseudotropicalissC. kruseisC. glabrata,
which re£ects the hierarchy observed in the ability of these
species to cause disease in a variety of mammals [25] and
also their predominance as human pathogens [23,24,28].
The data obtained here con¢rm that it is possible to dis-
tinguish between di¡erent levels of pathogenicity within
the genus Candida using G. mellonella larvae.
The dominant growth morphology of C. albicans in in-
sect haemolymph is the budding form although a small
percentage of hyphal forms have been observed. Both
growth morphologies are observed in human tissue in-
fected with C. albicans [22]. The exact means employed
by the yeast isolates to kill insect larvae has yet to be
elucidated as has the relative importance of speci¢c viru-
lence factors in overcoming the insect’s immune response.
Larvae of G. mellonella may provide an attractive and
reproducible model compared to other commonly used
systems for investigating the relative pathogenicities of
Candida species. Larvae are easy to culture under sterile
conditions and can be manipulated with ease. Large num-
bers can be inoculated per assay and results are obtainable
within 2 to 3 days. This model system will not provide
data on the role of the mammalian immune system in
combating pathogenic yeasts nor will it provide informa-
tion on the interaction of pathogenic yeasts with mamma-
lian tissue but it will allow a primary analysis of the rel-
ative pathogenicity of a variety of yeast pathogens. This
system should have applications where the pathogenicity
of yeast mutants needs to be established or where large
numbers of yeast isolates must be screened. It could be
used as an initial screen before conventional in vivo testing
or to minimise the need for routine mammalian testing.
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